Immuno-oncology is a promising new front in the fight against cancer. Exploiting the existence of tumor-specific antigens, immunotherapies aim to entrain the body’s immune system to specifically target and destroy cancer cells.

Systematic and reliable profiling of cytokine levels from biofluids and small tissue samples helps scientists capture valuable information about immune responses in individual patients, understand and predict therapeutic outcomes, and identify the key mechanisms by which the immune system fights cancer. LUNARIS™ Kits enable precise, multiplexed protein profiling that is being widely used and thoroughly tested. Incorporated into research strategies, these kits offer the opportunity to gain further translational insights into using the immune system to eradicate cancer cells.